Skip to main content
Fig. 2 | Antimicrobial Resistance & Infection Control

Fig. 2

From: Antibiotic utilisation and resistance over the first decade of nationally funded antimicrobial stewardship programmes in Singapore acute-care hospitals

Fig. 2

Trends in antibiotic utilisation rate (daily defined doses per 1,000 inpatient-days) across five public acute-care hospitals for (A) All broad-spectrum antibiotics, (B) Anti-pseudomonal antibiotics, (C) Third-generation cephalosporins, (D) Carbapenems, (E) Quinolones, (F) Beta-lactam/beta-lactamase inhibitors, first half of 2011 to second half of 2020. The | symbols denote the joinpoints identified using joinpoint regression analysis. Anti-pseudomonal antibiotics comprise cefepime, ceftazidime, ciprofloxacin, colistin, doripenem, imipenem, meropenem, levofloxacin, piperacillin-tazobactam and polymyxin B. Third generation cephalosporins comprise ceftazidime and ceftriaxone. Carbapenems comprise ertapenem, imipenem, meropenem and doripenem. Quinolones comprise ciprofloxacin, levofloxacin and moxifloxacin. Beta-lactam/beta-lactamase inhibitors comprise amoxicillin-clavulanate and piperacillin-tazobactam

Back to article page

Antimicrobial Resistance & Infection Control

ISSN: 2047-2994

Contact us